Singapore markets closed

IGC Pharma, Inc. (IGC)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.5000+0.0106 (+2.17%)
At close: 04:00PM EDT
0.5000 0.00 (0.00%)
Pre-market: 07:01AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Assets
Current assets
Cash
Cash and cash equivalents
3,196
10,460
14,548
7,258
Other short-term investments
154
0
80
5,081
Total cash
3,350
10,460
14,628
12,339
Net receivables
107
125
175
133
Inventory
2,651
3,548
5,478
4,245
Other current assets
262
336
196
223
Total current assets
6,466
15,111
23,517
17,757
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
10,475
13,089
14,162
12,781
Accumulated depreciation
-1,936
-3,220
-2,834
-2,427
Net property, plant and equipment
8,539
9,869
11,328
10,354
Equity and other investments
-
0
12
11
Intangible assets
1,170
917
407
252
Total non-current assets
10,712
11,723
12,350
11,227
Total assets
17,178
26,834
35,867
28,984
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
3
304
50
Accounts payable
530
981
476
762
Accrued liabilities
-
-
-
424
Other current liabilities
358
180
430
298
Total current liabilities
1,898
2,441
2,368
1,946
Non-current liabilities
Long-term debt
141
144
276
-
Total non-current liabilities
369
501
696
501
Total liabilities
2,267
2,942
3,064
2,447
Stockholders' equity
Common stock
118,965
116,019
109,720
94,754
Retained earnings
-100,665
-89,159
-74,143
-65,367
Accumulated other comprehensive income
-3,389
-2,968
-2,774
-2,850
Total stockholders' equity
14,911
23,892
32,803
26,537
Total liabilities and stockholders' equity
17,178
26,834
35,867
28,984